AKT1 and lung carcinoma: WDR72 has been recognized as a prognostic biomarker in non-small cell lung cancer, where it modulates the AKT/HIF-1α signaling pathway, contributing to enhanced lung cancer stemness (Ouyang et al., 2022; Shi et al., 2023).